High Potency Vitamin D3 10,000 IU
Single vitamin or mineral · 120 servings
Not backed for Bone health
Doesn't help: bone strength and shape
- Evidence Not backed
- Dose 1 of 1 at a studied dose
- Safety Read the label's warnings
- Fillers None of concern
What's in it
The dose here lands inside the range studies actually used.
Supplement Facts
Serving Size: 1 Softgel(s) (every three days)
120 per container
- Vitamin D3 as Cholecalciferol 250 mcg 1,250%
Other ingredients: Extra Virgin Olive Oil, Bovine Gelatin, Glycerin, Water, Safflower Oil.
Suggested use: Take 1 softgel every 3 days with a fat-containing meal, or as directed by your healthcare practitioner.
Doses against the trials
-

Vitamin D3
At the studied dose
83.33 mcg a day studies used 5–300 mcg · 115 studies
Worth knowing
The label's warnings
Cautions/Interactions: Although the upper limit for vitamin D is 4,000 IU per day, comprehensive research demonstrates that higher dosages are safe. However, this product should be taken under the supervision of a healthcare professional. Vitamin D should be used cautiously by those taking cardiac glycosides and anyone with hypercalcemia.
Vitamin D supplements may interact with atorvastatin and thiazide diuretics. If you are taking any of these prescription medications, consult your healthcare practitioner before using this product.
Not manufactured with yeast, wheat, gluten, soy, corn, milk, egg, fish, shellfish or sesame ingredients. Produced in a GMP facility that processes other ingredients containing these allergens.
Reported side effects
Hypercalciuria, Nausea, Hypercalcemia, Headache, Dizziness, Hypercalcaemia
The other ingredients
Clean formula. The inactive ingredients are standard capsule components.
- Extra Virgin Olive Oil
- Bovine Gelatin: capsule shell; neutral unless ethical concern
- Glycerin: capsule plasticizer; benign
- Water
- Safflower Oil
Free from
Halal, Gluten Free, Dairy Free. Non-GMO
Protocol For Life Balance
86 out of 100
Brand audit score
Protocol For Life Balance presents a credible quality posture and moderate transparency, but independent trust remains limited because the available evidence is mostly company-controlled.




